GnRH for Kallmann Syndrome
This trial is testing whether kisspeptin can help diagnose which children with delayed puberty will eventually enter puberty on their own, and which children have a permanent condition.
- Kallmann Syndrome
- Gonadotropin-Releasing Hormone Deficiency
- Delayed Puberty
- Hypogonadotropic Hypogonadism
Inclusion CriteriaYou will be eligible if you check “Yes” for the criteria below
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Side effects dataFrom 2009 Phase 2 trial • 36 Patients • NCT00586898
Awards & Highlights
Find a site
Who is running the clinical trial?
Frequently Asked Questions
What is the uppermost participation limit for this experiment?
"Affirmative, the clinical trial website presents information that this research is presently recruiting participants. This study was first advertised on November 1st 2011 and has been modified recently on June 29th 2022. The investigators have scheduled to accept 60 test subjects from a single medical facility."
Can I be considered as a participant in this experiment?
"Sixty participants aged between 12 and 17 who are experiencing a delay in puberty will be accepted into this medical trial. To qualify, adolescent girls must have Tanner stage I or II breast development with no changes for the past 6 months; boys should weigh more than 28kg and present a bone age less than their chronological age."
Has research been conducted with the hormone GnRH before?
"Presently, 46 trials exploring GnRH are underway. 10 of these being in the later stages (Phase 3). Although most research on this hormone is based out of Chicago Illinois, 1321 other locations host studies for this therapy."
Are there any potential hazards associated with GnRH administration?
"Our team has assigned GnRH a score of 1 due to lack of evidence for the drug's efficacy and safety, as it is only in its first stage of clinical trials."
Is the recruiting process for this research experiment currently underway?
"Yes, there is evidence on clinicaltrials.gov that this medical trial is actively recruiting participants. Initially posted in November 2011 and last edited June 2022, the study seeks to enrol 60 patients at a single location."
Is this medical study open to minors?
"As stated in the inclusion criteria, only minors between 12 and 17 years of age can join this clinical trial."